CELL INTELLIGENCE · 肿瘤细胞治疗研究

免疫治疗和靶向治疗联合化疗在老年 HER2 阳性胃食管结合部癌患者中的长期生存：一例病例报告

Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction ca

HER2（3+）和PD-L1（<5%）免疫组化染色为阳性。